Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



ROUBIN GARY S Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 4 ROUBIN GARY S (Director) has filed a Form 4 on InspireMD, Inc.
Txns: Granted 2,652 shares @ $0
07/05/2023 4 ROUBIN GARY S (Director) has filed a Form 4 on InspireMD, Inc.
Txns: Granted 3,445 shares @ $0
05/19/2023 4 ROUBIN GARY S (Director) has filed a Form 4 on InspireMD, Inc.
Txns: Granted 149,260 shares @ $0
Granted 49,750 options to buy @ $1.76, valued at $87.6k
05/16/2023 4 ROUBIN GARY S (Director) has filed a Form 4 on InspireMD, Inc.
Txns: Bought 61,249 shares @ $1.6327, valued at $100k
Bought 30,625 options to buy @ $1.3827, valued at $42.3k
Bought 30,624 options to buy @ $1.3827, valued at $42.3k
04/04/2023 4 ROUBIN GARY S (Director) has filed a Form 4 on InspireMD, Inc.
Txns: Granted 8,102 shares @ $0
08/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/18/2021 4 ROUBIN GARY S (Director) has filed a Form 4 on InspireMD, Inc.
Txns: Bought 25,640 shares @ $3.856, valued at $98.9k
Bought 290 shares @ $3.77, valued at $1.1k
10/14/2021 4 ROUBIN GARY S (Director) has filed a Form 4 on InspireMD, Inc.
Txns: Granted 17,248 shares @ $0
Granted 5,749 options to buy @ $4.12, valued at $23.7k
08/26/2021 4 ROUBIN GARY S (Director) has filed a Form 4 on InspireMD, Inc.
Txns: Bought 22,249 shares @ $4.191, valued at $93.2k
04/21/2021 4 ROUBIN GARY S (Director) has filed a Form 4 on InspireMD, Inc.
Txns: Granted 75,000 options to buy @ $0.46, valued at $34.5k
02/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/19/2020 4 ROUBIN GARY S (Director) has filed a Form 4 on InspireMD, Inc.
Txns: Bought 222,223 shares @ $0.45, valued at $100k
Bought 222,223 warrants @ $0.495, valued at $110k
10/16/2020 3 ROUBIN GARY S (Director) has filed a Form 3 on InspireMD, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy